Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

Values are mean ± SD, or N(%). ICU: intensive care unit, PTA: percutaneous transluminal angioplasty. In the AL group, 41 patients (61.4%) received additional treatment. Seven patients (10.0%) received ...

With clinical trials results trickling in, “antiaging” drugs that clear away senescent cells are proving to be promising — ...

Pleasanton, California - BosterBio's expertise in antibody production and its exceptional technical support and educational ...

EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy MISSISSAUGA, Ontario and ...

Dr. Li presented the results of a network meta-analysis comparing new-generation thrombolytic agents in acute ischemic stroke within 4.5 hours of onset, focusing on tenecteplase, reteplase, and ...

Monopar Therapeutics Inc.’s MNPR share price has surged by 15.06%, which has investors questioning if this is right time to sell.